Azalea Vision Enrolls the First Patient in a Proof-of-Concept Study Evaluating a NOA (Novel Optical Aperture) for Keratoconus and Presbyopia.
5 Articles
5 Articles
GAND, Belgium--(BUSINESS WIRE)--set 28, 2026
In collaboration with the daily newspaper L'Adige we receive and publish the link of the following news. Opinione thanks the publisher for the multimedia partnership. /// Azalea Vision enlists the first patient in a validation study aimed at evaluating a new optical opening for the keratocon and presbyopia.
Azalea Vision Enrolls First Patient in Proof-of-Concept Study Evaluating Novel Optical Aperture for Keratoconus and Presbyopia
Azalea Vision has enrolled the first patient in its NOA proof-of-concept study, which launches the company’s clinical program. The study evaluates a NOA (Novel Optical Aperture) in a contact lens in two patient groups: keratoconus and presbyopia. The results of the clinical study are expected to provide information for the planned first-in-human evaluation of Azalea’s fully […]
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium









